Back to
CITADEL ADVISORS LLC
AKTXShowing 2 of 12 quarters
Position history for
CITADEL ADVISORS LLC's holdings in AKARI THERAPEUTICS PLC
CITADEL ADVISORS LLC previously held 0 shares of AKTX (AKARI THERAPEUTICS PLC), worth $0 as of 2024-Q4.
Final Value
$0
Final Shares
0
Total Value Change
-$99,115
Total Shares Change
-33,260
Quarter-by-Quarter History
Other major holders of AKTX: Cresset Asset Management, LLC, RENAISSANCE TECHNOLOGIES LLC, DEUTSCHE BANK AG\